Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Myeloid 4Other hematologic neoplasm 3Genitourinary 3Gastrointestinal 3Dermatologic 2Tumor-Agnostic 1Gynecologic 1

Conditions

Melanoma 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Whole-Body Irradiation 27Specimen Handling 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × guadecitabine × Dermatologic × Clear all
NCT04250246 2020-01-31

NIBIT-ML1

Italian Network for Tumor Biotherapy Foundation

Phase 2 Unknown
184 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02608437 2015-11-18

NIBIT-M4

Italian Network for Tumor Biotherapy Foundation

Phase 1 Unknown
19 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡